Concepedia

Yasmin Karimi

YK

16

Publications

513

Citations

12

H-Index

2020

Active since

Affiliations

University of Michigan(Current)

Genmab (United States)

AbbVie (United States)

Icahn School of Medicine at Mount Sinai

Michigan Center for Translational Pathology

Yasmin Karimi is an author at University of Michigan specializing in immunology, oncology, and immunotherapy.

ORCID

Top concepts

Publications per year

2020–2025

16

Publications

16

Consensus recommendations on the management of toxicity associated with CD3×CD20 bispecific antibody therapy

Jennifer L. Crombie, Tara Graff, Lorenzo Falchi et al. · Blood · 2024 · 106 citations · Full text

NCCN Guidelines® Insights: B-Cell Lymphomas, Version 6.2023

Andrew D. Zelenetz, Leo I. Gordon, Jeremy S. Abramson et al. · Journal of the National Comprehensive Cancer Network · 2023 · 100 citations · Full text

Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial

Catherine Thiéblemont, Yasmin Karimi, Hervé Ghesquières et al. · Leukemia · 2024 · 87 citations · Full text

Epcoritamab plus GemOx in transplant-ineligible relapsed/refractory DLBCL: results from the EPCORE NHL-2 trial

Joshua Brody, Judit Jørgensen, David Belada et al. · Blood · 2025 · 35 citations · Full text

, , +19

Development and Use of Natural Language Processing for Identification of Distant Cancer Recurrence and Sites of Distant Recurrence Using Unstructured Electronic Health Record Data

Yasmin Karimi, Douglas W. Blayney, Allison W. Kurian et al. · JCO Clinical Cancer Informatics · 2021 · 29 citations · Full text

Rows per page

1–5 of 16